CN¥ 60.05
Key Takeaways
Risk factor
Good trading liquidity
Profitability factor
Overvalued vs peers
About
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science,...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, reasonably pr
Target Price
The average target price of 300347.SZ is 61 and suggests 0% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
